The company's initial focus is on the development of tesetaxel, an investigational, orally administered chemotherapy agent
belonging to the taxane class.
Temozolomide is an important chemotherapy agent
used to treat a certain type of brain tumor.
DAVANAT([R]) is currently in Phase II colorectal and biliary trials with chemotherapy agents
such as 5-FU, AVASTIN([R]) and leucovorin.
They selected out six which if missing or faulty would prevent the chemotherapy agent
paclitaxel working properly.
In the mid-stage trial, patients were randomized either to doxorubicin, a chemotherapy agent
used for sarcoma, or to palifosfamide in combination with doxorubicin, the company said.
The patient then decides to incorporate intravenous vitamin C alongside the chemotherapy agent
(Adriamycin) and from that point begins to respond and shrink the tumor unlike never before--and to the surprise of the oncologist.
The chemical was shown to be an effective chemotherapy agent
in laboratory and in some animal tests.
The therapy involves the breast cancer chemotherapy agent
doxorubicin and the bisphosphonate drug zoledronic acid.
The drug developer is focusing on its picoplatin product, a new generation platinum-based chemotherapy agent
which is in phase III clinical trials for small cell lung cancer.
1 Cancer Research, Romanio and his colleague report that the chemotherapy agent
doxorubicin and similar compounds accumulate in vesicles shed by cancer cells.
SBI) have entered into a development agreement to accelerate introduction of a blood test expected to help oncologists more effectively dose 5-fluorouracil (5-FU), a widely used chemotherapy agent
Patent & Trademark Office issued two new patents covering methods and composition for reducing toxicity of a toxic agent, and co-administration of a carbohydrate with a chemotherapy agent
to treat cancer.
Additionally, GX15-070 showed an additive effect with doxorubicin, a chemotherapy agent
Tarceva is currently approved as a monotherapy for the treatment of advanced non-small cell lung cancer (NSCLC) patients who have failed prior chemotherapy and in combination with the chemotherapy agent
gemcitabine for the treatment of chemotherapy-naive, advanced pancreatic cancer patients.
Patent and Trademark Office issued two new patents covering methods and compositions for reducing toxicity of a toxic agent, and co-administration of a carbohydrate with a chemotherapy agent
to treat cancer.